Literature DB >> 32315026

Responding to the COVID-19 Outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems.

Htet Lin Htun1, Dwee Wee Lim1,2, Win Mar Kyaw1, Wan-Ning Janis Loh1, Lay Tin Lee2, Brenda Ang3,4, Angela Chow1,4.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV-2) and first reported in Wuhan, China, in December 2019. Since the severe acute respiratory syndrome (SARS) outbreak in 2003, Tan Tock Seng Hospital (TTSH) in Singapore has routinely fit-tested staff for high-filtration N95 respirators and established Web-based staff surveillance systems. The routine systems were enhanced in response to Singapore's first imported COVID-19 case on 23 January 2020.
METHODS: We conducted a cross-sectional study from 23 January to 23 February 2020 among healthcare workers to evaluate the effectiveness of the staff protection and surveillance strategy in TTSH, a 1600-bed multidisciplinary acute-care hospital colocated with the 330-bed National Centre for Infectious Diseases (NCID). As of 23 February 2020, TTSH/NCID has managed 76% of confirmed COVID-19 cases in Singapore. The hospital adopted a multipronged approach to protect and monitor staff with potential COVID-19 exposures: (1) risk-based personal protective equipment, (2) staff fever and sickness surveillance, and (3) enhanced medical surveillance of unwell staff.
RESULTS: A total of 10 583 staff were placed on hospitalwide fever and sickness surveillance, with 1524 frontline staff working in COVID-19 areas under close surveillance. Among frontline staff, a median of 8 staff illness episodes was seen per day; almost 10% (n = 29) resulted in hospitalization. None of the staff was found to be infected with COVID-19.
CONCLUSIONS: A robust staff protection and health surveillance system that is routinely implemented during non-outbreak periods and enhanced during the COVID-19 outbreak is effective in protecting frontline staff from the infection.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; disease outbreaks; personal protective equipment; health personnel; severe acute respiratory syndrome coronavirus 2

Mesh:

Year:  2020        PMID: 32315026      PMCID: PMC7188160          DOI: 10.1093/cid/ciaa468

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Staff and patient surveillance in hospitals: Good sentinels for the emergence of new SARS-CoV-2 variants.

Authors:  Rhea Khanna; Htet Lin Htun; Anthony Lianjie Li; Win Mar Kyaw; Hou Ang; Brenda Ang; Angela Chow
Journal:  J Infect       Date:  2022-07-08       Impact factor: 38.637

2.  Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.

Authors:  Vania Hungria; Marcia Garnica; Edvan de Queiroz Crusoé; Roberto Jose Pessoa de Magalhaes Filho; Gracia Martinez; Rosane Bittencourt; Danielle Leão Cordeiro de Farias; Walter Moises Braga; Jorge Vaz Pinto Neto; Glaciano Nogueira Ribeiro; Angelo Maiolino
Journal:  Hematol Transfus Cell Ther       Date:  2020-05-13

3.  Diligent Medical Activities of a Publicly Designated Medical Institution for Infectious Diseases Pave the Way for Overcoming COVID-19: A Positive Message to People Working at the Cutting Edge.

Authors:  Tatsuya Nagano; Jun Arii; Mitsuhiro Nishimura; Naofumi Yoshida; Keiji Iida; Yoshihiro Nishimura; Yasuko Mori
Journal:  Clin Infect Dis       Date:  2021-02-16       Impact factor: 9.079

4.  Effects of the COVID-19 pandemic on supply and use of blood for transfusion.

Authors:  Simon J Stanworth; Helen V New; Torunn O Apelseth; Susan Brunskill; Rebecca Cardigan; Carolyn Doree; Marc Germain; Mindy Goldman; Edwin Massey; Daniele Prati; Nadine Shehata; Cynthia So-Osman; Jecko Thachil
Journal:  Lancet Haematol       Date:  2020-07-03       Impact factor: 18.959

5.  Source Analysis and Effective Control of a COVID-19 Outbreak in a University Teaching Hospital during a Period of Increasing Community Prevalence of COVID-19.

Authors:  Unhee Lee; Seong Eun Kim; Seung Yeob Lee; Hang Nam Wi; Okja Choi; Ji Won Park; Dahee Kim; You Jung Kim; Hwa Young Shin; Mihee Kim; Eun Ji Kim; Seung Ji Kang; Sook In Jung; Kyung Hwa Park
Journal:  J Korean Med Sci       Date:  2021-06-21       Impact factor: 2.153

6.  Utilizing the electronic health records to create a syndromic staff surveillance system during the COVID-19 outbreak.

Authors:  Jean Xiang Ying Sim; Edwin Philip Conceicao; Liang En Wee; May Kyawt Aung; Sylvia Yi Wei Seow; Raymond Chee Yang Teo; Jia Qing Goh; Dennis Wu Ting Yeo; Benjamin Jyhhan Kuo; John Wah Lim; Wee Hoe Gan; Moi Lin Ling; Indumathi Venkatachalam
Journal:  Am J Infect Control       Date:  2020-11-04       Impact factor: 2.918

7.  Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital.

Authors:  Qi Wang; Xiaotao Zhao; Zhihong Yue; Xiaohui Bai; Huiying Rao; Na Han; Tianbing Wang; Hui Wang; Baoguo Jiang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 8.  Information technology in emergency management of COVID-19 outbreak.

Authors:  Afsoon Asadzadeh; Saba Pakkhoo; Mahsa Mirzaei Saeidabad; Hero Khezri; Reza Ferdousi
Journal:  Inform Med Unlocked       Date:  2020-11-13

9.  Asymptomatic health-care worker screening during the COVID-19 pandemic.

Authors:  Angela Chow; Htet Lin Htun; Win Mar Kyaw; Lay Tin Lee; Brenda Ang
Journal:  Lancet       Date:  2020-10-31       Impact factor: 79.321

10.  The Impact of COVID-19 on Neurosurgical Services in Africa.

Authors:  Muhammad Raji Mahmud; Beverly Cheserem; Ignatius N Esene; Kazadi Kalangu; Samuila Sanoussi; Aaron Musara; Nasser M F El-Ghandour; Graham Fieggen; Mahmood Qureshi
Journal:  World Neurosurg       Date:  2020-11-25       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.